SEC Form 4 · accession 0001127602-18-009030

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman & CEO · Director

Period of report

Feb 26, 2018

Accepted (ET)

Feb 28, 2018 · 3:15 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 26, 2018	S	100	$106.85	D	326,338	D
Common Stock	Feb 26, 2018	S	397	$106.86	D	325,941	D
Common Stock	Feb 26, 2018	S	200	$106.87	D	325,741	D
Common Stock	Feb 26, 2018	S	100	$106.90	D	325,641	D
Common Stock	Feb 26, 2018	S	103	$106.915	D	325,538	D
Common Stock	Feb 26, 2018	S	200	$106.935	D	325,338	D
Common Stock	Feb 26, 2018	S	400	$106.95	D	324,938	D
Common Stock	Feb 26, 2018	S	1	$106.96	D	324,937	D
Common Stock	Feb 26, 2018	S	100	$106.97	D	324,837	D
Common Stock	Feb 26, 2018	S	540	$106.975	D	324,297	D
Common Stock	Feb 26, 2018	S	49	$106.98	D	324,248	D
Common Stock	Feb 26, 2018	S	201	$106.985	D	324,047	D
Common Stock	Feb 26, 2018	S	710	$106.99	D	323,337	D
Common Stock	Feb 26, 2018	S	100	$107.015	D	323,237	D
Common Stock	Feb 26, 2018	S	400	$107.02	D	322,837	D
Common Stock	Feb 26, 2018	S	100	$107.025	D	322,737	D
Common Stock	Feb 26, 2018	S	200	$107.045	D	322,537	D
Common Stock	Feb 26, 2018	S	400	$107.05	D	322,137	D
Common Stock	Feb 26, 2018	S	300	$107.07	D	321,837	D
Common Stock	Feb 26, 2018	S	552	$107.08	D	321,285	D
Common Stock	Feb 26, 2018	S	300	$107.09	D	320,985	D
Common Stock	Feb 26, 2018	S	100	$107.115	D	320,885	D
Common Stock	Feb 26, 2018	S	90	$107.12	D	320,795	D
Common Stock	Feb 26, 2018	S	84	$107.125	D	320,711	D

No Table II lines on this filing.